| Literature DB >> 29074720 |
Mohamed E Abdel-Latif1,2, Gen Nowak3, Barbara Bajuk4, Kathryn Glass5, David Harley5,6.
Abstract
BACKGROUND: Studying centre-to-centre (CTC) variation in mortality rates is important because inferences about quality of care can be made permitting changes in practice to improve outcomes. However, comparisons between hospitals can be misleading unless there is adjustment for population characteristics and severity of illness.Entities:
Keywords: benchmarking; mortality; premature; variation
Mesh:
Year: 2017 PMID: 29074720 PMCID: PMC6047145 DOI: 10.1136/archdischild-2017-313222
Source DB: PubMed Journal: Arch Dis Child Fetal Neonatal Ed ISSN: 1359-2998 Impact factor: 5.747
Maternal characteristics of the study group stratified by admitting hospital A to H
| Characteristic | A | B | C | D | E | F | G | H | All |
| Maternal age, years | 29.0(24.0–33.0) | 30.0(26.0–35.0) | 29.0 | 32.0 | 32.0 | 32.0 | 29.0 | 30.0 | 30.0(26.0–35.0) |
| Indigenous Australian | 129 (10.5) | 34 (3.4) | 39 (4.0) | 38 (4.3) | 43 (5.0) | 24 (2.8) | 70 (8.9) | 49 (7.6) | 426 (5.9) |
| Assisted conception | 105 (8.6) | 156 (15.6) | 104 (10.8) | 136 (15.3) | 129 (15.1) | 141 (16.6) | 77 (9.8) | 73 (11.3) | 921 (12.8) |
| Multiple pregnancy | 338 (27.6) | 271 (27.1) | 276 (28.7) | 279 (31.4) | 251 (29.3) | 244 (28.8) | 185 (23.6) | 205 (31.7) | 2049 (28.4) |
| Hypertension in pregnancy | 231 (18.9) | 216 (21.6) | 143 (14.8) | 202 (22.7) | 165 (19.3) | 153 (18.0) | 157 (20.0) | 121 (18.7) | 1388 (19.2) |
| Chorioamnionitis | 161 (13.1) | 293 (29.3) | 229 (23.8) | 152 (17.1) | 297 (34.7) | 232 (27.4) | 111 (14.1) | 219 (34.0) | 1694 (23.5) |
| Intrauterine growth restriction | 145 (11.8) | 158 (15.8) | 123 (12.8) | 166 (18.7) | 143 (16.7) | 124 (14.6) | 100 (12.7) | 84 (13.0) | 1043 (14.5) |
| Antenatally diagnosed malformation | 19 (1.6) | 27 (2.7) | 20 (2.1) | 34 (3.8) | 4 (0.5) | 10 (1.2) | 9 (1.1) | 20 (3.1) | 143 (2.0) |
| Any antenatal steroids | 1119 (91.3) | 849 (84.9) | 885 (91.9) | 822 (92.5) | 805 (94.0) | 780 (92.0) | 712 (90.7) | 588 (91.0) | 6560 (91.0) |
| Vaginal breech delivery | 82 (6.7) | 84 (8.4) | 63 (6.5) | 54 (6.1) | 28 (3.3) | 34 (4.0) | 36 (4.6) | 39 (6.0) | 420 (5.8) |
| Caesarean section | 681 (55.6) | 594 (59.4) | 561 (58.3) | 578 (65.0) | 601 (70.2) | 551 (65.0) | 517 (65.9) | 385 (59.6) | 4468 (62.0) |
Data are presented as median (IQR) for maternal age and n (%) for all other variables. Chorioamnionitis includes clinically suspected as well as pathologically proven cases.
Neonatal characteristics of the study group stratified by admitting hospital A to H
| Characteristic | A | B | C | D | E | F | G | H | All |
| Onsite surgical support | Yes | No | No | Yes | No | No | No | Yes | – |
| Born in non-tertiary hospital | 155 (12.7) | 89 (8.9) | 97 (10.1) | 94 (10.6) | 78 (9.1) | 99 (11.7) | 74 (9.4) | 61 (9.4) | 747 (10.4) |
| Male gender | 687 (56.1) | 531 (53.1) | 501 (52.0) | 481 (54.1) | 460 (53.7) | 478 (56.4) | 409 (52.1) | 345 (53.4) | 3892 (54.0) |
| Gestational age, week* | 29.0 (27.0–31.0) | 29.0 (27.0–30.0) | 29.0 (27.0–31.0) | 29.0 (27.0–30.0) | 29.0 (27.0–30.0) | 29.0 (27.0–30.0) | 29.0 (27.0–31.0) | 29.0 (27.0–31.0) | 30.0 (29.0–31.0) |
| Birth weight, g* | 1270 (960.0–1550.0) | 1200.0 (910.0–1494.0) | 1240.0 (938.0–1536.0) | 1235.0 (940.0–1547.0) | 12 250.0 (960.0–1520.0) | 1220.0 (930.0–1502.0) | 1260.0 (960.0–1559.0) | 1290.0 (980.0–1550.0) | 1240.0 (950.0–1530.0) |
| Birth weight<10th percentile | 82 (6.7) | 99 (10.0) | 72 (7.5) | 60 (6.8) | 72 (8.5) | 69 (8.2) | 57 (7.3) | 50 (7.8) | 561 (7.8) |
| Head circumference<10th percentile | 47 (3.9) | 26 (2.8) | 34 (4.0) | 47 (5.5) | 33 (4.1) | 31 (3.8) | 25 (3.4) | 22 (3.4) | 265 (3.9) |
| Apgar score<7 at 5 min | 213 (17.5) | 218 (21.9) | 211 (22.0) | 173 (19.5) | 191 (22.4) | 158 (18.7) | 140 (17.9) | 156 (24.2) | 1460 (20.3) |
| Surfactant | 642 (52.4) | 741 (74.1) | 509 (52.9) | 534 (60.1) | 572 (66.8) | 516 (60.8) | 580 (73.9) | 373 (57.7) | 4467 (61.9) |
| Postnatal steroids | 32 (2.6) | 66 (6.6) | 62 (6.4) | 82 (9.2) | 54 (6.3) | 69 (8.1) | 59 (7.5) | 44 (6.8) | 468 (6.5) |
Other than for onsite surgical support data are presented as median (IQR)* or n (%).
Neonatal mortality of the study group stratified by admitting hospital A to H
| Hospital | A | B | C | D | E | F | G | H | All |
| Observed mortality | 107 (8.7) | 69 (6.9) | 100 (10.4) | 71 (8.0) | 45 (5.3) | 69 (8.1) | 63 (8.0) | 48 (7.4) | 572 (7.9) |
| Expected mortality | 94 (7.7) | 89 (8.9) | 83 (8.6) | 70 (7.8) | 58 (6.7) | 63 (7.4) | 56 (7.2) | 47 (7.3) | 560 (7.8) |
| Standardised mortality ratio | 1.14 (0.94–1.37) | 0.77 (0.61–0.97) | 1.21 (0.98–1.46) | 1.06 (0.84–1.32) | 0.78 (0.57–1.03) | 1.10 (0.86–1.38) | 1.12 (0.87–1.43) | 1.02 (0.76–1.34) | 1.02 (0.94–1.11) |
| Risk-adjusted mortality | 110 (9.0) | 61 (6.1) | 92 (9.6) | 72 (8.1) | 53 (6.2) | 74 (8.7) | 69 (8.8) | 52 (8.1) | 584 (8.1) |
Data are presented as n (%) (95% CI). Expected hospital mortality was calculated using a multiple logistic regression model adjusted for ethnicity, assisted conception, multiple gestation, hypertensive disease of pregnancy, antenatally diagnosed malformation, chorioamnionitis, any antenatal steroids, outborn, method of birth, gender, gestational age, birth weight percentiles, Apgar score <7 at 5 min and postnatal steroid.
Figure 1Funnel plot showing observed mortality rates in neonatal intensive care units in New South Wales and Australian Capital Territory between 2007 and 2014 for infants born at 23 to 31 (A), 23 to 26 (B), 27 to 28 (C) and 29 to 31 (D) weeks of gestation. Average, 95% and 99.8% lower and upper control limits are shown.
Figure 2Funnel plot showing risk-adjusted hospital mortality in neonatal intensive care units in New South Wales and Australian Capital Territory for infants born at 23 to 31 (A), 23 to 26 (B), 27 to 28 (C) and 29 to 31 (D) weeks of gestation. Average, 95% and 99.8% lower and upper control limits are shown.